Home›People›Jason Pitts
JP

Jason Pitts

Director at Seaport Therapeutics.

DirectorPublic company
Updated Nov 2, 2026·Latest SEC filing Apr 30, 2026·Suggest an edit

About Jason Pitts

Jason Pitts is a director at Seaport Therapeutics.

Jason Pitts reports to the SEC as a director of 2 public companies, including CinCor Pharma (CINC).

Jason Pitts first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Jason Pitts in the role, so the role may have started earlier or lasted longer.

Seaport Therapeutics, Inc.
Director
2024 – 2026 · Public company (SPTX)
CinCor Pharma, Inc.
Director
2022 · Public company (CINC)

Key Colleagues at Startups

The people Jason Pitts works with at each company, as listed on that company's latest Form D.

Seaport Therapeutics, Inc. · Form D, Oct 31, 2024
JH
James Healy
Director
MC
Michael Chen
Executive officer
LG
Lana Gladstein
General Counsel
DZ
Daphne Zohar
Executive officer and director
AL
Antony Loebel
Executive officer
DW
EG
Eric Green
Executive officer
RN
SP
Steven Paul
Director
DT
EE
Eric Elenko
Director

Sources

  1. SECSeaport Therapeutics, Inc. Form D, filed Oct 31, 2024
  2. SECForms 3, 4 and 5 filed by Jason Pitts (SEC filer 1821346)